Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2026-01-04 @ 1:06 AM
Study NCT ID:
NCT00622466
Status:
TERMINATED
Last Update Posted:
2020-10-19
First Post:
2008-02-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer
Sponsor:
University of Texas Southwestern Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STU 082010-161
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None